Mirae Asset Global ETFs Holdings
BBNX

Mirae Asset Global ETFs Holdings’s Beta Bionics BBNX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$714K Buy
71,211
+16,670
+31% +$247K ﹤0.01% 1693
2025
Q4 		$1.66M Sell
54,541
-725
-1% -$19.4K ﹤0.01% 1242
2025
Q3 		$1.1M Buy
55,266
+47,806
+641% +$840K ﹤0.01% 1432
2025
Q2 		$109K Sell
7,460
-312
-4% -$4.42K ﹤0.01% 2572
2025
Q1 		$95.1K Buy
+7,772
New +$145K ﹤0.01% 2656

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mirae Asset Global ETFs Holdings's BBNX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Beta Bionics (BBNX) stake by 31% in Q1 2026, buying an estimated $247K and bringing the position to 71,211 shares worth $714K. The position accounts for ﹤0.01% of the portfolio, ranked #1693.

Mirae Asset Global ETFs Holdings first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.66M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 71,211 shares of Beta Bionics worth $714K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 16,670 Beta Bionics shares in Q1 2026, an estimated $247K.
  • Beta Bionics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1693 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Beta Bionics position peaked at $1.66M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.